PRIA Logo™
MarylandHB 14612026 Regular SessionHouse

Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions

Sponsored By: Deni Taveras (Democratic)

In Committee

Health - InsuranceDrugs -see also- Cannabis; ControlDangSubst; Pharm; etc.Health -see also- COVID19; EnvHlth; MedCon; etc.Health Insurance -see also- ACA; HMOs; MCOsHealth Maintenance Organizations -see also- Manage Care OrgsMedical Conditions -see also- AIDS; COVID-19; rabiesMedical TreatmentsNonprofit OrganizationsPharmacy Benefits ManagersPharmacists and Pharmacies -see also- Drugs

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Deni Taveras

    Democratic • House

Cosponsors

  • Mary A. Lehman

    Democratic • House

  • Nicole A. Williams

    Democratic • House

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Hearing 3/13 at 1:30 p.m.

    3/13/2026House

  2. Hearing canceled

    3/13/2026House

  3. Hearing 3/13 at 3:00 p.m.

    3/13/2026House

  4. Hearing canceled

    3/13/2026House

  5. Hearing 3/13 at 1:00 p.m.

    2/13/2026House

  6. First Reading Health

    2/13/2026House

Bill Text

  • First Reading

    2/13/2026

    PDF

Related Bills

Back to State Legislation